1. Home
  2. ADCT vs SATL Comparison

ADCT vs SATL Comparison

Compare ADCT & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

N/A

Current Price

$4.19

Market Cap

484.4M

Sector

Health Care

ML Signal

N/A

Logo Satellogic Inc.

SATL

Satellogic Inc.

N/A

Current Price

$3.16

Market Cap

482.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ADCT
SATL
Founded
2011
2010
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
484.4M
482.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ADCT
SATL
Price
$4.19
$3.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$7.50
$6.00
AVG Volume (30 Days)
801.2K
4.2M
Earning Date
03-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
44.90
N/A
EPS
N/A
N/A
Revenue
$70,837,000.00
N/A
Revenue This Year
$14.96
$21.31
Revenue Next Year
$1.06
$84.23
P/E Ratio
N/A
N/A
Revenue Growth
1.84
N/A
52 Week Low
$1.05
$1.26
52 Week High
$4.80
$5.93

Technical Indicators

Market Signals
Indicator
ADCT
SATL
Relative Strength Index (RSI) 54.53 47.40
Support Level $3.93 $2.73
Resistance Level $4.71 $3.94
Average True Range (ATR) 0.24 0.28
MACD -0.02 -0.01
Stochastic Oscillator 33.56 24.23

Price Performance

Historical Comparison
ADCT
SATL

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About SATL Satellogic Inc.

Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.

Share on Social Networks: